Scaling Success - BiomeBank gets a write up in the Medical Daily.
BiomeBank gets included on a list of 'The Best Startups Shaping The Next Era Of Innnovation'
LA weekly covers BiomeBank in this article.
Media Release: Australian biotech company BiomeBank has successfully secured a multimillion-dollar Federal Government grant that will turbo charge the development and production of microbiome-based therapies.
BiomeBank today announced the opening of its new GMP manufacturing facility designed to increase global supply of its approved donor derived microbiome-based therapy and further develop its second-generation therapies.
BiomeBank has announced the appointment of Kolby Day to the new position of Chief Operating Officer at the biotech drug development company based in Adelaide, South Australia.
Formal Therapeutic Goods Administration (“TGA”) approval of BiomeBank’s first-generation donor derived microbiome-based therapy.
Page Contents Overview The human body is inhabited by trillions of microscopic organisms including bacteria, viruses, fungi and archaea. Although they’re too small to see with the naked eye, microbes inhabit almost every part of the human body, including on our skin, up our nose and inside our gut. Collectively…
The translation of research into the development of innovative and life-saving microbial therapies is set to transform in Australia through a partnership between Hudson Institute of Medical Research and BiomeBank, a clinical stage microbiome therapeutics company.